New Approaches to Coronary Heart Disease

@article{Stegmann2012NewAT,
  title={New Approaches to Coronary Heart Disease},
  author={T. Stegmann},
  journal={BioDrugs},
  year={2012},
  volume={11},
  pages={301-308}
}
  • T. Stegmann
  • Published 2012
  • Medicine
  • BioDrugs
  • Currently available approaches for treating human coronary heart disease aim to relieve symptoms and the risk of myocardial infarction by reducing myocardial oxygen demand (drugs), preventing further disease progression (drugs), restoring coronary blood flow either pharmacologically (thrombolysis) or mechanically (angioplasty), or bypassing the stenotic lesions and obstructed coronary artery segments (surgery). Direct gene therapy, as well as gene-derived therapy, especially by angiogenic… CONTINUE READING
    Multimodality Imaging of Angiogenesis
    • 2
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 53 REFERENCES
    Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis
    • 327
    Basic fibroblast growth factor enhances myocardial collateral flow in a canine model.
    • 319
    Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.
    • 503
    Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
    • 936
    • Highly Influential
    Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.
    • 1,085
    • Highly Influential
    • PDF
    Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.
    • 311